Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Related Articles by Review for PubMed (Select 10426862)

1.

Reperfusion injury: experimental evidence and clinical implications.

Ambrosio G, Tritto I.

Am Heart J. 1999 Aug;138(2 Pt 2):S69-75. Review.

PMID:
10426862
2.

The role of neutrophils in myocardial ischemia-reperfusion injury.

Jordan JE, Zhao ZQ, Vinten-Johansen J.

Cardiovasc Res. 1999 Sep;43(4):860-78. Review.

3.

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.

Kloner RA, Jennings RB.

Circulation. 2001 Dec 11;104(24):2981-9. Review.

4.

Myocardial reperfusion injury: etiology, mechanisms, and therapies.

Hoffman JW Jr, Gilbert TB, Poston RS, Silldorff EP.

J Extra Corpor Technol. 2004 Dec;36(4):391-411. Review.

PMID:
15679285
5.

[Possible significance of free oxygen radicals for reperfusion injury].

Becker BF, Massoudy P, Permanetter B, Raschke P, Zahler S.

Z Kardiol. 1993;82 Suppl 5:49-58. Review. German.

PMID:
8154162
6.

Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.

Pagliaro P, Chiribiri A, Mancardi D, Rastaldo R, Gattullo D, Losano G.

Ital Heart J. 2003 Jun;4(6):383-94. Review.

PMID:
12898803
7.

Neutrophils and myocardial reperfusion injury.

Williams FM.

Pharmacol Ther. 1996;72(1):1-12. Review.

PMID:
8981567
8.

Complement, neutrophils and free radicals: mediators of reperfusion injury.

Lucchesi BR.

Arzneimittelforschung. 1994 Mar;44(3A):420-32. Review.

PMID:
8185717
9.

Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.

Stangl V, Baumann G, Stangl K, Felix SB.

Cardiovasc Res. 2002 Jan;53(1):12-30. Review.

10.

Role of oxygen in postischemic myocardial injury.

Kutala VK, Khan M, Angelos MG, Kuppusamy P.

Antioxid Redox Signal. 2007 Aug;9(8):1193-206. Review.

PMID:
17571958
11.

Mechanism of myocardial "stunning".

Bolli R.

Circulation. 1990 Sep;82(3):723-38. Review.

PMID:
2203553
12.

Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications.

Forman MB, Puett DW, Virmani R.

J Am Coll Cardiol. 1989 Feb;13(2):450-9. Review.

13.

Complement activation in heart diseases. Role of oxidants.

Chakraborti T, Mandal A, Mandal M, Das S, Chakraborti S.

Cell Signal. 2000 Oct;12(9-10):607-17. Review.

PMID:
11080612
14.

Mechanisms and therapy of myocardial reperfusion injury.

Forman MB, Virmani R, Puett DW.

Circulation. 1990 Mar;81(3 Suppl):IV69-78. Review.

PMID:
2407376
15.

The role of oxidants and free radicals in reperfusion injury.

Zweier JL, Talukder MA.

Cardiovasc Res. 2006 May 1;70(2):181-90. Epub 2006 Mar 3. Review.

16.

Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2.

Kloner RA, Jennings RB.

Circulation. 2001 Dec 18;104(25):3158-67. Review.

17.

Pathophysiology of the no-reflow phenomenon.

Vrints CJ.

Acute Card Care. 2009;11(2):69-76. doi: 10.1080/17482940902978061. Review.

PMID:
19526383
18.

Mechanisms of myocardial reperfusion injury.

Park JL, Lucchesi BR.

Ann Thorac Surg. 1999 Nov;68(5):1905-12. Review.

PMID:
10585102
19.

Ischaemic heart disease: clinical improvement with metabolic approach.

Ferrari R.

Rev Port Cardiol. 2000 Nov;19 Suppl 5:V7-20. Review.

PMID:
11206104
20.

Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion.

Korthuis RJ, Granger DN.

Clin Cardiol. 1993 Apr;16(4 Suppl 1):I19-26. Review.

PMID:
8472394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk